查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1722534

2025 年至 2033 年骨骼生長刺激器市場報告（按產品、應用、最終用戶和地區）

Bone Growth Stimulator Market Report by Product, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球骨骼生長刺激器市場規模達 22 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 34 億美元，2025-2033 年期間的成長率 (CAGR) 為 4.8%。由於事故、運動傷害和年齡相關因素導致的骨折發生率不斷上升、方便用戶使用型設備的不斷發展以及對非侵入性治療方案的偏好日益增加，市場正在經歷穩定的成長。

骨骼生長刺激器市場分析：

主要市場促進因素：根據骨骼生長刺激器市場前景，關鍵促進因素包括運動相關損傷的增加、對加速骨骼癒合和縮短恢復時間的好處的認知，以及快速的技術進步，例如電磁和超音波刺激器的發展。

主要市場趨勢：根據骨骼生長刺激器市場統計數據，值得注意的趨勢包括向非侵入性治療的持續轉變、對攜帶式、方便用戶使用型設備的需求不斷成長以及再生醫學的持續進步。

地理趨勢：受完善的醫療保健基礎設施的推動，北美引領市場。然而，由於患者越來越關注強化治療方案，亞太地區正成為一個快速成長的市場。

競爭格局：骨骼生長刺激器產業的主要市場參與者包括 Arthrex Inc.、DJO Global Inc.、Elizur Corporation、IGEA SpA、Isto Biologics、Ito Co. Ltd.、Medical Device Business Services Inc. (Johnson & Johnson)、Medtronic Plc、Orthofix Medical Inc.、Ossatec Corporation Inc. (Johnson & Johnson)、Medtronic Plc、Orthofix Medical Inc.、Ossatec Corporation Benelctux B.Sker.

挑戰與機會：根據骨骼生長刺激器市場概況，市場面臨挑戰，例如需要持續的研究驗證。它還面臨著開發更先進、更具成本效益的設備的機會。

骨骼生長刺激器市場趨勢：

骨折發生率上升

由於個人骨折發生率的上升，骨骼生長刺激器的採用率不斷提高，這對骨骼生長刺激器的使用產生了積極影響。與此一致，骨折可能由於各種原因發生，例如事故、運動傷害和年齡相關因素。根據世界衛生組織 (WHO) 的數據，每年有 2,000 萬至 5,000 萬人在道路交通事故中遭受非致命傷害，導致骨折和損傷，需要有效的治療。此外，由於老年人由於骨密度降低而更容易出現骨折問題，因此老年族群中骨骼生長刺激器的使用率不斷上升，這也推動了市場的成長。除此之外，骨骼生長刺激器為更快、更有效的骨骼癒合提供了可行的解決方案，使其成為醫療保健專業人員和患者的首選。此外，患者對增強治療方案的關注度不斷提高，也推動了骨骼生長刺激器市場的發展。此外，人們越來越喜歡骨骼生長刺激器，因為與傳統的骨折治療相比，它們有助於更快地恢復並減輕疼痛。

技術進步

技術進步有助於開發更先進、更有效率、更用戶友善的設備，進而促進市場成長。此外，擴大使用結合電磁場、超音波和脈衝電磁場 (PEMF) 等先進技術的骨骼生長刺激器來刺激骨骼再生，有利於市場成長。除此之外，改進的設備設計和功能不僅可以提高治療效果，還可以提高患者的依從性。此外，由於患者可以將其融入日常生活中，小型、便攜且具有先進控制功能的設備擴大被採用，從而支撐了骨骼生長模擬器的市場佔有率。與此相符的是，醫療保健提供者正在為他們的患者尋求有效且基於證據的解決方案。此外，大眾對更有效、更有吸引力的治療方案的需求不斷成長，推動了市場的成長。此外，配備無線連接的先進骨骼生長刺激器的引入，使醫療保健提供者能夠遠端監控患者的依從性和治療進展。例如，Orthofix Medical Inc 宣布美國 FDA 批准行動應用程式版本 2.1 STIMonTrack 以推進骨骼生長刺激器的發展。

非侵入性治療方案的偏好日益增加

患者對非侵入性和無痛治療方案的需求不斷增加，這對骨骼生長刺激器市場收入產生了積極推動作用。與此相符的是，患者擴大尋求手術和侵入性手術的替代方案。此外，骨骼生長刺激器為骨骼癒合提供了非手術選擇。此外，非侵入性治療不僅可以減輕患者的不適，還可以最大限度地降低併發症和感染的風險。這使得骨骼生長刺激器對廣大患者特別有吸引力，包括那些對手術猶豫不決或對侵入性手術有禁忌症的患者。除此之外，非侵入性治療通常可以縮短恢復時間，使患者能夠更快地恢復日常活動。此外，對以患者為中心的方法的日益關注也促進了市場的成長。此外，與外科手術相比，非侵入性治療更具成本效益，因為它們需要更少的醫院資源、更短的住院時間並降低整體醫療保健費用，這對骨骼生長刺激器市場價格產生積極影響。

骨骼生長刺激器市場細分：

按產品分類：

  • 骨骼生長刺激裝置
  • 骨形態發生蛋白
  • 富血小板血漿

骨骼生長刺激裝置佔大部分市場佔有率

根據以產品為基礎的骨骼生長刺激器市場細分，骨骼生長刺激裝置佔有最大的佔有率。它們是旨在促進骨骼自然癒合的非侵入性醫療器材。它們的工作原理是將特定類型的能量（例如電磁場、超音波或電流）傳送到骨骼損傷或骨折部位。與此一致，這些設備通常具有多種形式，例如穿戴式支架、攜帶式裝置或可植入裝置。設備的選擇取決於骨折的性質和位置。它們加速成骨細胞等骨形成細胞的產生，幫助修復和再生受損的骨組織。

按應用分類：

  • 脊椎融合手術
  • 骨折延遲癒合和不癒合
  • 口腔顎面外科
  • 其他

脊椎融合手術佔據行業最大佔有率

根據骨骼生長刺激器市場趨勢，脊椎融合手術佔據最大的市場佔有率。它們涉及連接脊椎中的兩個或多個椎骨，以治療脊椎不穩定、退化性椎間盤疾病或脊椎骨折等疾病。在脊椎融合中，骨骼生長刺激器在促進融合過程中發揮關鍵作用。它們刺激手術部位的骨骼癒合，幫助椎骨更有效、更安全地融合在一起。脊椎相關疾病的增加以及對改善手術效果的需求不斷成長，對骨骼生長刺激器的未來產生了積極影響。

按最終用戶分類：

  • 醫院和診所
  • 居家護理
  • 其他

醫院和診所是主要的細分市場

根據骨骼生長刺激器市場細分，醫院和診所經常在各種應用中使用骨骼生長刺激器，包括骨科手術、骨折管理和術後護理。在醫院中，這些刺激器被骨科醫生和物理治療部門用來幫助治療骨折、脊椎融合手術和其他骨科疾病。醫院和診所的機構設置確保患者在使用骨骼生長刺激器期間得到專家的照顧和指導。

按地區分類：

  • 北美洲
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

北美引領市場，佔據最大的骨骼生長刺激器市場佔有率

該報告還對所有主要區域市場進行了全面的分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。根據報告，北美是骨骼生長促效劑最大的區域市場。

根據骨骼生長刺激器市場趨勢，北美由於擁有完善的醫療保健基礎設施（如醫院和診所）佔據了最大的市場佔有率。同時，主要參與者正在開發先進的骨骼生長刺激器設備，以促進該地區市場的成長。此外，為確保提高安全性和有效性，醫療器材的嚴格監管架構正在推動市場成長。

競爭格局：

市場研究報告也對市場競爭格局進行了全面的分析。也提供了所有主要公司的詳細資料。骨骼生長刺激器產業的主要市場參與者包括 Arthrex Inc.、DJO Global Inc.、Elizur Corporation、IGEA SpA、Isto Biologics、Ito Co. Ltd.、Medical Device Business Services Inc. (Johnson & Johnson)、Medtronic Plc、Orthofix Medical Inc.、Ossatec Benelux BV、Stry Bimmerel.

（請注意，這只是關鍵參與者的部分列表，完整列表在報告中提供。）

最近的報告分析了骨骼生長刺激器市場的規模，強調該行業的主要參與者正專注於透過結合先進技術、改進設備設計和提高治療效果來開發先進的骨骼生長刺激器設備。為此，各公司正在進行臨床試驗，以證明其產品的安全性和有效性。此外，他們正在擴大其產品組合，提供一系列骨骼生長刺激器選項，例如根據特定應用量身定做的設備，包括脊椎融合或骨折癒合，對骨骼生長刺激器市場價格產生積極影響。除此之外，製造商也與醫療機構、研究組織和學術機構合作，促進骨骼生長刺激器技術的研究、開發和驗證。此外，他們正在與監管機構密切合作，以獲得其設備的批准和認證。

骨骼生長刺激器市場新聞：

2020 年 2 月 13 日：專注於肌肉骨骼產品和療法的全球醫療器材公司 Orthofix Medical Inc. 宣布，美國食品藥物管理局 (FDA) 批准將 STIM onTrack 行動應用程式 2.1 版與該公司的骨骼生長刺激器一起使用。行動裝置應用程式是一款旨在幫助患者遵守處方並改善臨床結果的配件。

2020 年 1 月 8 日：美敦力公司收購了位於伊利諾伊州布盧明頓的私人控股公司 Stimgenics, LLC，該公司率先推出了一種稱為差異靶連接複用 (DTM(TM)) 脊髓刺激的新型脊髓刺激 (SCS) 波形。該療法透過美敦力 Intellis 平台提供，是一種治療慢性疼痛患者的全新獨特的程式選項。

2021 年 5 月 17 日：IGEA SpA 與 Orthofix Medical Inc. 簽署獨家授權協議，以在海外商業化一系列專用於刺激的創新產品。此外，骨骼生長刺激和關節保護裝置將在美國和加拿大商業化。

本報告回答的關鍵問題

  • 骨骼生長促效劑市場有多大
  • 2025-2033年全球骨骼生長刺激器市場的預期成長率是多少
  • 推動全球骨骼生長刺激器市場的關鍵因素有哪些
  • COVID-19 對全球骨骼生長促效劑市場有何影響
  • 根據產品類型，全球骨骼生長刺激器市場如何分類？
  • 根據應用，全球骨骼生長刺激器市場如何分類
  • 根據最終用戶，全球骨骼生長刺激器市場的分佈如何
  • 全球骨骼生長促效劑市場的主要區域有哪些
  • 全球骨骼生長促效劑市場的主要參與者/公司有哪些

本報告回答的關鍵問題

  • 骨骼生長促效劑市場有多大？ 2025 年至 2033 年期間全球骨骼生長刺激器市場的預期成長率為何？
  • 推動全球骨骼生長刺激器市場發展的關鍵因素有哪些？
  • COVID-19 對全球骨骼生長刺激器市場有何影響？
  • 根據產品，全球骨骼生長刺激器市場是如何分佈的？
  • 根據應用，全球骨骼生長刺激器市場是如何分佈的？
  • 根據最終用戶，全球骨骼生長刺激器市場的分佈如何？
  • 全球骨骼生長刺激器市場的主要區域有哪些？
  • 全球骨骼生長刺激器市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球骨骼生長促效劑市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 骨骼生長刺激裝置
  • 骨形態發生蛋白
  • 富血小板血漿

第7章：市場區隔：依應用

  • 脊椎融合手術
  • 骨折延遲癒合和不癒合
  • 口腔顎面外科
  • 其他

第8章：市場區隔：按最終用戶

  • 醫院和診所
  • 居家護理
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Arthrex Inc.
    • DJO Global Inc.
    • Elizur Corporation
    • IGEA SpA
    • Isto Biologics
    • Ito Co. Ltd.
    • Medical Device Business Services Inc. (Johnson & Johnson)
    • Medtronic Plc
    • Orthofix Medical Inc.
    • Ossatec Benelux BV
    • Stryker Corporation
    • Terumo Bct Inc. (Terumo Corporation)
    • Zimmer Biomet
Product Code: SR112025A5741

The global bone growth stimulator market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033. The market is experiencing stable growth driven by the growing incidences of bone fractures due to accidents, sports injuries, and age-related factors, rising development of user-friendly devices, and increasing preferences for non-invasive treatment solutions.

Bone Growth Stimulator Market Analysis:

Major Market Drivers: According to the bone growth stimulator market outlook, key drivers include the rising sports-related injuries, awareness about the benefits of accelerated bone healing and reduced recovery time, and rapid technological advancements, such as the development of electromagnetic and ultrasound-based stimulators.

Key Market Trends: Based on the bone growth stimulator market statistics, notable trends include the ongoing shift towards non-invasive treatments, growing demand for portable, user-friendly devices, and ongoing advancements in regenerative medicine.

Geographical Trends: North America leads the market, driven by the presence of well-established healthcare infrastructure. However, Asia Pacific is emerging as a fast-growing market due to the increasing focus on enhanced treatment solutions among patients.

Competitive Landscape: Some of the major market players in the bone growth stimulator industry include Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation), and Zimmer Biomet, among many others.

Challenges and Opportunities: As per the bone growth stimulator market overview, the market faces challenges, such as the need for continuous research validation. It also encounters opportunities in developing more advanced and cost-effective devices.

Bone Growth Stimulator Market Trends:

Rising incidences of bone fractures

The growing adoption of bone growth stimulators due to rising incidences of bone fractures among individuals is positively impacting the uses of bone growth stimulator. In line with this, bone fractures can occur due to various reasons, such as accidents, sports injuries, and age-related factors. According to the World Health Organization (WHO), between 20 and 50 million people suffer non-fatal injuries in road accidents, leading to fracturs and injuries that require effective treatment options. Moreover, the rising employment of bone growth stimulators among the geriatric population, as they are more prone to fracture issues due to reduced bone density, is propelling the growth of the market. Apart from this, bone growth stimulators offer a viable solution for quicker and more effective bone healing, making them a preferred choice among healthcare professionals and patients. In addition, the increasing focus on enhanced treatment solutions among patients is impelling the bone growth stimulator market opportunities. Furthermore, people are increasingly preferring bone growth stimulators, as they assist in faster recovery and reduced pain as compared to traditional fracture treatments.

Technological advancements

Technological advancements assist in the development of more advanced, efficient, and user-friendly devices, which is contributing to the market growth. In addition, the increasing use of bone growth stimulators that incorporate advanced technologies, such as electromagnetic fields, ultrasound, and pulsed electromagnetic fields (PEMF), to stimulate bone regeneration, is favoring the market growth. Apart from this, improved device design and functionality not only enhance treatment outcomes but also improve patient compliance. Furthermore, the rising adoption of smaller and portable devices with advanced control, as they allow patients to incorporate them into their daily routines, is supporting the bone growth simulator market share. In line with this, healthcare providers are seeking effective and evidence-based solutions for their patients. Additionally, the increasing demand for more effective and appealing treatment options among the masses is propelling the market growth. Moreover, the introduction of advanced bone growth stimulators that are equipped with wireless connectivity, enables healthcare providers to monitor patient compliance and treatment progress remotely. For instance, Orthofix Medical Inc announced U.S. FDA approval of mobile app version 2.1 STIMonTrack to advance bone growth stimulators.

Increasing preferences for non-invasive treatment solutions

The increasing demand for non-invasive and painless treatment options among patients is positively impelling the bone growth stimulator market revenue. In line with this, patients are increasingly seeking alternatives to surgery and invasive procedures. Additionally, bone growth stimulators provide a non-surgical option for bone healing. Furthermore, non-invasive treatments not only reduce patient discomfort but also minimize the risk of complications and infection. This makes bone growth stimulators particularly appealing to a broad spectrum of patients, including those who are hesitant about surgery or have contraindications for invasive procedures. Apart from this, non-invasive treatments often lead to shorter recovery times, allowing patients to resume their daily activities more quickly. Moreover, the rising focus on patient-centric approaches is bolstering the market growth. In addition, non-invasive treatments are more cost-effective as compared to surgical procedures, as they require fewer hospital resources, shorter hospital stays, and reduce overall healthcare expenses, which is positively influencing the bone growth stimulator market price.

Bone Growth Stimulator Market Segmentation:

Breakup by Product:

  • Bone Growth Stimulation Devices
  • Bone Morphogenetic Proteins
  • Platelet-Rich Plasma

Bone growth stimulation devices accounts for the majority of the market share

According to the bone growth stimulator market segment based on the product, bone growth stimulation devices hold the largest share. They are non-invasive medical instruments designed to promote the natural healing of bones. They work by delivering specific types of energy, such as electromagnetic fields, ultrasound waves, or electrical currents, to the site of the bone injury or fracture. In line with this, these devices are usually available in various forms, such as wearable braces, portable units, or implantable options. The choice of device depends on the nature and location of the fracture. They accelerate the production of bone-forming cells, such as osteoblasts, aiding in the repair and regeneration of damaged bone tissues.

Breakup by Application:

  • Spinal Fusion Surgeries
  • Delayed Union and Nonunion Bone Fractures
  • Oral and Maxillofacial Surgeries
  • Others

Spinal fusion surgeries hold the largest share of the industry

According to the bone growth stimulator market trends, spinal fusion surgeries represented the largest market share. They involve joining two or more vertebrae in the spine to treat conditions like spinal instability, degenerative disc disease, or spinal fractures. In spinal fusion, bone growth stimulators play a critical role in promoting the fusion process. They stimulate bone healing at the surgical site, helping the vertebrae to fuse together more effectively and securely. The growing number of spinal-related conditions, along with the rising need for improved surgical outcomes, is positively impacting the future of bone growth stimulators.

Breakup by End User:

  • Hospitals and Clinics
  • Home Care
  • Others

Hospitals and clinics represent the leading market segment

As per the bone growth stimulator market segments, hospitals and clinics often use bone growth stimulators in various applications, including orthopedic surgeries, fracture management, and post-operative care. In hospitals, these stimulators are employed by orthopedic surgeons and in physical therapy departments to aid in the healing of bone fractures, spinal fusion procedures, and other orthopedic conditions. The institutional setting of hospitals and clinics ensures that patients receive expert care and guidance during the use of bone growth stimulators.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest bone growth stimulator market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for bone growth stimulator.

According to the bone growth stimulator market trends, North America accounted for the largest market share due to the presence of well-established healthcare infrastructure, such as hospitals and clinics. In line with this, key players are developing advanced bone growth stimulator devices, which are bolstering the growth of the market in the region. Moreover, stringent regulatory frameworks for medical devices to ensure enhanced safety and efficacy are propelling the market growth.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the bone growth stimulator industry include Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation), Zimmer Biomet, etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent reports analyzing how big is the bone growth stimulator market highlighted that key players in the industry are focusing on developing advanced bone growth stimulator devices by incorporating advanced technologies, improving device design, and enhancing treatment efficacy. In line with this, companies are conducting clinical trials to demonstrate the safety and effectiveness of their products. Moreover, they are expanding their product portfolios to offer a range of bone growth stimulator options, such as devices tailored as per specific applications, including spinal fusion or fracture healing, positively impacting the bone growth stimulator market price. Apart from this, manufacturers are collaborating with healthcare institutions, research organizations, and academic institutions to facilitate research, development, and the validation of bone growth stimulator technologies. Furthermore, they are working closely with regulatory authorities to obtain approvals and certifications for their devices.

Bone Growth Stimulator Market News:

February 13, 2020: Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies, announced that the U.S. Food and Drug Administration (FDA) approved the use of STIM onTrack mobile app version 2.1 with the bone growth stimulators of the company. The mobile device app is an accessory designed to help patients adhere to their prescriptions and improve their clinical outcomes.

January 8, 2020: Medtronic Plc acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has pioneered a novel spinal cord stimulation (SCS) waveform known as Differential Target Multiplexed (DTM(TM)) spinal cord stimulation. The therapy, which is delivered via the Medtronic Intellis platform, is a new and unique programming option to treat patients with chronic pain.

May 17, 2021: IGEA S.p.A. signed an exclusive license agreement with Orthofix Medical Inc. to commercialize overseas the range of innovative products dedicated to stimulation. In addition, the bone growth stimulation and joint preservation devices will be commercialized in the United States and Canada.

Key Questions Answered in This Report

  • 1.How big is the bone growth stimulator market?
  • 2.What is the expected growth rate of the global bone growth stimulator market during 2025-2033?
  • 3.What are the key factors driving the global bone growth stimulator market?
  • 4.What has been the impact of COVID-19 on the global bone growth stimulator market?
  • 5.What is the breakup of the global bone growth stimulator market based on the product?
  • 6.What is the breakup of the global bone growth stimulator market based on the application?
  • 7.What is the breakup of the global bone growth stimulator market based on the end user?
  • 8.What are the key regions in the global bone growth stimulator market?
  • 9.Who are the key players/companies in the global bone growth stimulator market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bone Growth Stimulator Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Bone Growth Stimulation Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bone Morphogenetic Proteins
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Platelet-Rich Plasma
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Spinal Fusion Surgeries
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Delayed Union and Nonunion Bone Fractures
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Oral and Maxillofacial Surgeries
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Care
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Arthrex Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 DJO Global Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Elizur Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 IGEA S.p.A.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Isto Biologics
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Ito Co. Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Medical Device Business Services Inc. (Johnson & Johnson)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Medtronic Plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Orthofix Medical Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Ossatec Benelux B.V.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stryker Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Terumo Bct Inc. (Terumo Corporation)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 SWOT Analysis
    • 14.3.13 Zimmer Biomet
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Bone Growth Stimulator Market: Major Drivers and Challenges
  • Figure 2: Global: Bone Growth Stimulator Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Bone Growth Stimulator Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Bone Growth Stimulator Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Bone Growth Stimulator Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Bone Growth Stimulator Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Bone Growth Stimulator Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Bone Growth Stimulator (Bone Growth Stimulation Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Bone Growth Stimulator (Bone Growth Stimulation Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Bone Growth Stimulator (Bone Morphogenetic Proteins) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Bone Growth Stimulator (Bone Morphogenetic Proteins) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Bone Growth Stimulator (Platelet-Rich Plasma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Bone Growth Stimulator (Platelet-Rich Plasma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Bone Growth Stimulator (Spinal Fusion Surgeries) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Bone Growth Stimulator (Spinal Fusion Surgeries) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Bone Growth Stimulator (Delayed Union and Nonunion Bone Fractures) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Bone Growth Stimulator (Delayed Union and Nonunion Bone Fractures) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Bone Growth Stimulator (Oral and Maxillofacial Surgeries) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Bone Growth Stimulator (Oral and Maxillofacial Surgeries) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Bone Growth Stimulator (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Bone Growth Stimulator (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Bone Growth Stimulator (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Bone Growth Stimulator (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Bone Growth Stimulator (Home Care) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Bone Growth Stimulator (Home Care) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Bone Growth Stimulator (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Bone Growth Stimulator (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Bone Growth Stimulator Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Bone Growth Stimulator Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Bone Growth Stimulator Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Bone Growth Stimulator Industry: SWOT Analysis
  • Figure 78: Global: Bone Growth Stimulator Industry: Value Chain Analysis
  • Figure 79: Global: Bone Growth Stimulator Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bone Growth Stimulator Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Bone Growth Stimulator Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Bone Growth Stimulator Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Bone Growth Stimulator Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Bone Growth Stimulator Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Bone Growth Stimulator Market: Competitive Structure
  • Table 7: Global: Bone Growth Stimulator Market: Key Players